ITGR at a glance
Integer Holdings Corp (ITGR, SEC CIK 1114483) filed its latest 10-K annual report on February 23, 2026, a 10-Q quarterly report on October 29, 2026, an 8-K current report on November 17, 2026 and Form 4 insider filings as recently as November 19, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Integer Holdings Corp (ITGR) reported revenue of $1.9 billion (up 8.0% from FY2024) and net income of $102.8 million. Diluted EPS was $2.89.
- As of September 30, 2026, 29 institutional investment managers tracked by SignalX reported holding Integer Holdings Corp (ITGR) shares worth $2.1 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by KKR Group Partnership L.P. on November 17, 2026 of 4,753,677 shares at $127.00 per share.
- In the last 90 days, ITGR insiders reported 0 open-market purchases ($0) and 5 open-market sales ($1.2B) on Form 4, a net sale of $1.2B.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $1.9B
- +8.0% vs prior year
- Insiders · 90 days
- 0 buys · 5 sells
- Net −$1.2B
- 13F holders
- 29 funds
- $2.1B · −3 vs prior quarter
- Latest 8-K
- Nov 17, 2026
- Item 1.02 · Item 1.01 · Item 2.01 · Item 3.01 · Item 3.03 · Item 5.01 · Item 5.02 · Item 5.03 · Item 7.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Pure-play medtech CDMO focused on Cardio & Vascular, Neuromodulation, and Cardiac Rhythm Management markets
- Acquisitions in 2025: Biocoat, VSi Parylene, and Precision Coatings added surface coating technologies and complementary capabilities
- Strategic emphasis on tuck-in acquisitions to expand capabilities, enhance scale, and deepen customer penetration in high-growth markets
- Firm backlog orders $675 million at December 31, 2025, majority expected to ship within one year
- Ongoing exit plan from Portable Medical market initiated in 2021, with final sales and exit expected in 2026
Risk Factors
- Regulatory risk: Compliance with EU Corporate Sustainability Reporting Directive and California climate rules may increase costs and impact profitability
- Geopolitical risk: Supply chain exposed to wars in Ukraine and Middle East, U.S.-China tensions, tariffs on steel and copper impacting import costs
- Operational risk: Top 3 customers accounted for 49% revenues in 2025; loss or reduced demand from any would materially harm results
- Competitive risk: Intense competition from medical device companies with greater resources and risk of customer insourcing or dual sourcing
- Financial risk: Dependence on senior management and key technical personnel; loss may harm operations and require costly replacement efforts
Management Discussion & Analysis
- Revenue $1.854B, up 8.0% YoY ($137M increase); Cardio & Vascular strongest segment $1.107B (+16.6%), Other Markets weakest $77.8M (-26.9%)
- Gross margin 27.0% vs 26.7% YoY, gross profit up 9.0% ($41.4M); operating expenses up $28.3M; net income down to $102.8M from $121.1M
- Operating cash flow $196.1M, capex $91.0M, share repurchase $50.0M; acquisitions funded by $178.9M borrowings; net debt $1.185B end of year
- Issued $1B 2030 Convertible Notes; paid down prior debt; repurchased 698K shares for $50M; increased working capital by $94.1M
- 2026 capex guidance $95M-$105M; management expects cash flows and credit facilities sufficient for operations and debt service; risk from foreign currency and restructuring costs
AI summary of the ITGR 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Oct 2, 2026
Risk Factors
- Merger litigation risk: three stockholder complaints and 13 demand letters alleging Proxy Statement disclosure deficiencies
- Merger completion risk: lawsuits could delay or prevent closing
- Legal cost risk: defense and potential director indemnification costs could be substantial
- Carried-forward risks: no material changes from the December 31, 2025 Form 10-K except Merger litigation disclosures
Management Discussion & Analysis
- Q3 revenue $449.7M, down $18.0M, or 3.9% YoY
- Operating margin 6.3% vs 12.1%; gross margin 22.6% vs 27.0%
- Best line CRM&N: $175.8M, up $6.7M, or 3.9%; worst Other Markets: $10.8M, down $10.6M, or 49.7%
- Cash $14.1M vs $17.2M; nine-month operating cash flow $121.1M, capex $67.2M, repurchases $50.0M
- Outlook: merger anticipated by end of 2026; headwinds include lower product adoption, supply-chain pressures, inflation, tariffs and geopolitical uncertainty
AI summary of the ITGR 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 1.02: Termination of a Material Definitive Agreement
- Existing Credit Agreement fully repaid and terminated at merger closing
- Related collateral security interests released, reducing lender claims on company assets
Item 1.01: Entry into a Material Definitive Agreement
- $2.1B initial term loans plus $350M revolving capacity, supporting merger financing but materially increasing leverage
- Debt secured by substantially all borrower and guarantor assets, with Holdings and subsidiaries providing guarantees
Item 2.01: Completion of Acquisition or Disposition of Assets
- Acquisition completed at $127.00 cash per Integer common share
- Transaction converts Integer equity awards into cash, creating merger-related payouts for RSUs, PSUs and in-the-money options
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule
- Merger consummated, triggering suspension of Integer common-share trading before the Closing Date’s market open
- NYSE removal and Section 12(b) deregistration requested through Form 25
Item 3.03: Material Modification to Rights of Security Holders
- Merger closing eliminated existing ITGR common-shareholder rights at the Effective Time
- Former shareholders retained only the right to receive merger consideration under the Merger Agreement
Item 5.01: Changes in Control of Registrant
- Integer became a wholly owned subsidiary of Parent upon merger completion
- Approximately $5.4 billion total merger consideration
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Merger completion triggered full Board turnover, with all incumbent directors resigning
- Max Lin and Hunter Craig became directors of the surviving corporation
Item 5.03: Amendments to Articles of Incorporation or Bylaws
- Merger completion triggered full restatement of Integer’s certificate of incorporation and bylaws
- Amendments implement the merger agreement and establish the post-merger governance framework
Item 7.01: Regulation FD Disclosure
- Merger triggers conversion rights for 2028 and 2030 Notes through January 8, 2027
- 2028 Notes conversion value approximately $1,491.08 per $1,000, including 0.2734 Additional Shares
Item EX-99.2: Item EX-99.2
- KKR acquisition completed at approximately $5.7 billion enterprise value, marking Integer’s transition to private ownership
- Stockholders receive $127 per share in cash, providing a defined liquidity event for shareholders
Item EX-99.1: Item EX-99.1
- Merger completed November 17, 2026, making Integer a wholly owned subsidiary of Armstrong Parent
- Common shareholders received $127.00 cash per share, while convertible noteholders gained temporary conversion rights
Item 2.02: Results of Operations and Financial Condition
- Integer Holdings reported fiscal third-quarter results for the period ended October 2, 2026
- Exhibit 99.1 contains the company’s earnings release and detailed financial results
Item EX-99.1: Item EX-99.1
- Q3 2026 sales $449.7M, down 3.9%; organic sales down 2.2%, signaling weaker near-term demand
- GAAP operating income $28.2M, down 50%; adjusted operating income $66.3M, down 22.8%
Item 5.07: Submission of Matters to a Vote of Security Holders
- Merger with KKR-affiliated funds approved, clearing the key stockholder voting condition for the transaction
- 26,065,335 shares voted for adoption, versus 10,513 against and 1,993 abstentions
Item EX-99.1: Item EX-99.1
- Stockholders approved KKR-backed acquisition agreement, removing the primary shareholder approval condition
- Merger proposal received 99.95% of votes cast, representing 76.66% of total outstanding shares
Item 7.01: Regulation FD Disclosure
- Stockholders approved the Transaction, removing a key closing condition
- Closing targeted by year-end 2026, still subject to customary conditions
AI summaries of ITGR 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for ITGR
Don't miss the next ITGR filing
- Alerts as it files. A push when ITGR files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut ITGR, by share count.
- Ask anything. An AI agent that reads every ITGR filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Kapito Aaron | D | Nov 17, 2026 | 3,337.677 | - |
| Carr Terence | D | Nov 17, 2026 | 5,322 | - |
| KKR Group Partnership L.P. | Sell | Nov 17, 2026 | 4,753,677 | $127.00 |
| Metcalf Milo Stephen II | D | Nov 17, 2026 | 1,189 | - |
| Carr Terence | D | Nov 17, 2026 | 952 | - |
| KKR Group Partnership L.P. | C | Nov 17, 2026 | 836,392 | - |
| Tarheel Investors III L.P. | C | Nov 17, 2026 | 836,392 | - |
| Tarheel Investors III L.P. | Sell | Nov 17, 2026 | 4,753,677 | $127.00 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $1.7B | $1.9B |
| Gross Profit | - | $459.0M | $500.4M |
| Operating Income | - | $208.2M | $221.3M |
| Net Income | - | $119.9M | $102.8M |
| Gross Margin | - | 26.7% | 27.0% |
| Op. Margin | - | 12.1% | 11.9% |
| Net Margin | - | 7.0% | 5.5% |
| Balance Sheet | |||
| Total Assets | $2.9B | $3.1B | $3.4B |
| Equity | $1.5B | $1.6B | $1.7B |
| ROE | - | 7.4% | 5.9% |
| Per Share | |||
| EPS | - | $3.36 | $2.89 |
| Cash Flow | |||
| Operating CF | - | $205.2M | $196.1M |
| CapEx | - | $105.4M | $91.0M |
Source: XBRL data in Integer Holdings Corp (ITGR)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate ITGR share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 29 | $2.15B |
| Q2 2026 | 32 | $1.93B |
| Q1 2026 | 32 | $1.75B |
| Q4 2025 | 31 | $1.46B |
| Q3 2025 | 34 | $2.25B |
| Q2 2025 | 32 | $2.77B |
| Q1 2025 | 32 | $1.87B |
| Q4 2024 | 30 | $1.87B |
- Goldman Sachs Group+481.6K (+83%)
- Bank of America Corp+301.0K (+64%)
- JPMorgan Chase & Co+298.3K (+80%)
- Morgan Stanley+238.6K (+18%)
- Principal Financial Group+26.4K (+12%)
- Invesco Ltd−2.10M (-94%)
- Dimensional Fund Advisors−848.9K (-52%)
- Raymond James Financial−289.7K (-99%)
- Franklin Resources−218.1K (-93%)
- Citigroup−176.9K (-75%)
- Soros Fund Management+48.9K
- Citadel Advisors LLC−965.8K
- Truist Financial−9.7K
- FMR LLC (Fidelity)−7.7K
- Blackstone Group−2.9K
Source: 13F-HR filings on SEC EDGAR (aggregated from 252 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
ITGR filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 4 | Nov 19, 2026 | - | - | - |
| 8-K | Nov 17, 2026 | - | Analysis | - |
| 4 | Nov 17, 2026 | - | - | - |
| 4 | Nov 17, 2026 | - | - | - |
| 4 | Nov 17, 2026 | - | - | - |
| 8-K | Oct 29, 2026 | - | Analysis | - |
| 10-Q | Oct 29, 2026 | Oct 2, 2026 | Analysis | |
| 4 | Oct 26, 2026 | - | - | - |
Related Health Care companies
- AXGN · Axogen, Inc.Electromedical & Electrotherapeutic Apparatus
- BLFS · BIOLIFE SOLUTIONS INCElectromedical & Electrotherapeutic Apparatus
- CV · CapsoVision, IncElectromedical & Electrotherapeutic Apparatus
- CBLL · Ceribell, Inc.Electromedical & Electrotherapeutic Apparatus
- CNMD · CONMED CorpElectromedical & Electrotherapeutic Apparatus
- ELMD · Electromed, Inc.Electromedical & Electrotherapeutic Apparatus
- HYPR · Hyperfine IncElectromedical & Electrotherapeutic Apparatus
- LIVN · LivaNova PLCElectromedical & Electrotherapeutic Apparatus
ITGR SEC filings: frequently asked questions
Are ITGR insiders buying or selling?
In the last 90 days, Integer Holdings Corp (ITGR) officers, directors and 10% owners reported no open-market purchases and 5 open-market sales worth $1.2 billion by 4 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold ITGR stock?
As of September 30, 2026, the largest Integer Holdings Corp (ITGR) holders among the 13F filers tracked by SignalX were BlackRock ($671.9 million), Vanguard Portfolio Management LLC ($253.6 million), Morgan Stanley ($200.2 million), Vanguard Capital Management LLC ($192.5 million), State Street Corp ($173.5 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was ITGR's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Integer Holdings Corp (ITGR) reported revenue of $1.9 billion (up 8.0% from FY2024) and net income of $102.8 million. Diluted EPS was $2.89. The figures come from the XBRL data in the 10-K.
What are the main risks in ITGR's latest 10-K?
In the 10-K filed February 23, 2026, Integer Holdings Corp (ITGR) flagged: Regulatory risk: Compliance with EU Corporate Sustainability Reporting Directive and California climate rules may increase costs and impact profitability. Geopolitical risk: Supply chain exposed to wars in Ukraine and Middle East, U.S.-China tensions, tariffs on steel and copper impacting import costs. (AI summary of the Risk Factors section.)
What did ITGR report in its latest 8-K?
Integer Holdings Corp (ITGR) filed an 8-K on November 17, 2026 reporting Item 1.02 (Termination of a Material Definitive Agreement), Item 1.01 (Entry into a Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule), Item 3.03 (Material Modification to Rights of Security Holders), Item 5.01 (Changes in Control of Registrant), Item 5.02 (Departure/Appointment of Directors or Principal Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws) and Item 7.01 (Regulation FD Disclosure). Existing Credit Agreement fully repaid and terminated at merger closing.
What are the latest ITGR SEC filings?
Integer Holdings Corp (ITGR) filed its latest 10-K annual report on February 23, 2026, a 10-Q quarterly report on October 29, 2026, an 8-K current report on November 17, 2026 and a Form 4 insider filing on November 19, 2026.
What is ITGR's SEC CIK number?
Integer Holdings Corp (ITGR)'s SEC Central Index Key (CIK) is 1114483. EDGAR lists every ITGR filing under that number.
Ask anything about ITGR
The research agent reads ITGR's filings, financials, insider trades and 13F holders, then answers with sources.